Policy chaos and the demise of US exceptionalism. The story of US equities is a curious case of “self-inflicted pain”. Just when the S&P 500 as basking in the glory of being the “only game in town” following Trump’s election victory, the market gave up all its gains and started heading towards correction territory. The abrupt turnaround in fortunes lies squarely on the surge in policy uncertainties with the new administration unleashing a global tariff war and reshaping the world order with its “America First” agenda. The ensuing chaos is starting to weigh on business confidence and economic activities. ISM Manufacturing, for instance, fell to 50.3 in February and edged closer to contractionary territory while forecast from Atlanta Fed’s GDPNow is pointing to a -2.4% decline in GDP (vs a growth of 2.6% at the start of the year).
US consumers, meanwhile, are stuck between a rock and a hard place. Weakening macro conditions and looming job cuts coincided with plunging consumer confidence – which saw a 7-points dip to 98.3 in February, the biggest decline since Aug 2021 – while retail sales similarly corrected by 0.9% in January, the sharpest in two years. Yet, despite the dire consumption outlook, inflation remains stubbornly high and will only get worse if the tariff war escalates from here. Trump’s imposition of tariffs on Mexico, China, and Canada will affect a wide range of goods from delivery trucks and cars to petroleum – a strangely ironic situation considering Trump had made combating inflation the central rhetoric of his re-election campaign. The political optics of the new administration inflicting tariff pains at a time of resurgent inflation will not go down well with the American consumer.
When the unthinkable becomes reality – Investors “de-risking” from US equities. The acute correction on the S&P 500 and Nasdaq says it all. Investors are actively switching out of US equities to fund their positions in Europe and China. The very notion of “de-risking” from US equities, unthinkable just a month ago, is now becoming a reality. Under the “America First” policy agenda, the very rule-based global system that has served America so well for decades is crumbling. And with Trump announcing that this is “just getting started”, we see no immediate end in sight for the portfolio shifts away from the US.
Funds are pre-emptively switching out of the US based on expectations of a darkening economical and geopolitical mood. The change in sentiments, unfortunately, is coming at a time when US equities are trading at huge valuation premiums relative to the rest of the world. A “priced for perfection” market will need to see substantial unwinding before the negatives are fully priced-in and this is just only getting started. Forecasted earnings for the S&P 500 suggest that the downside has yet to be reflected in analysts’ forecasts and we anticipate more weakness ahead when downward earnings revisions begin.
Meanwhile, if the new administration thinks that they are “winning” this trade war, anecdotal evidence is suggesting otherwise. The “US Trump Tariff Losers” thematic basket, which tracks the performance of US stocks negatively exposed to Trump’s tariffs, has seen sharp correction since late-January while its European counterpart remains on a gradual uptrend. This suggests that the tariffs are hurting US companies more than their European peers.
2Q25 US Sector Strategy – Defensive shifts
Changing times call for changing strategy. Policy chaos means that businesses will hold back on their investment decisions until further clarity emerges. Similarly for consumers, purchases of big-ticket items will be postponed until the economic fog is lifted. Under such conditions, the US economic momentum will moderate, necessitating a recalibration of our US sector strategy. A more defensive tilt is necessary with the recent performance of US sectors already reflecting this new reality.
On a YTD basis, “crowded trades” like technology and consumer discretionary have lost 8.7% and 10.2% respectively (as at 6 Mar) while defensive sectors like healthcare (+8.6%) and consumer staples (+6.9%) have outperformed. For 2Q25, the key switches that we are making to our US sector allocation are:
The information published by DBS Bank Ltd. (company registration no.: 196800306E) (“DBS”) is for information only. It is based on information or opinions obtained from sources believed to be reliable (but which have not been independently verified by DBS, its related companies and affiliates (“DBS Group”)) and to the maximum extent permitted by law, DBS Group does not make any representation or warranty (express or implied) as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions and estimates are subject to change without notice. The publication and distribution of the information does not constitute nor does it imply any form of endorsement by DBS Group of any person, entity, services or products described or appearing in the information. Any past performance, projection, forecast or simulation of results is not necessarily indicative of the future or likely performance of any investment or securities. Foreign exchange transactions involve risks. You should note that fluctuations in foreign exchange rates may result in losses. You may wish to seek your own independent financial, tax, or legal advice or make such independent investigations as you consider necessary or appropriate.
The information published is not and does not constitute or form part of any offer, recommendation, invitation or solicitation to subscribe to or to enter into any transaction; nor is it calculated to invite, nor does it permit the making of offers to the public to subscribe to or enter into any transaction in any jurisdiction or country in which such offer, recommendation, invitation or solicitation is not authorised or to any person to whom it is unlawful to make such offer, recommendation, invitation or solicitation or where such offer, recommendation, invitation or solicitation would be contrary to law or regulation or which would subject DBS Group to any registration requirement within such jurisdiction or country, and should not be viewed as such. Without prejudice to the generality of the foregoing, the information, services or products described or appearing in the information are not specifically intended for or specifically targeted at the public in any specific jurisdiction.
The information is the property of DBS and is protected by applicable intellectual property laws. No reproduction, transmission, sale, distribution, publication, broadcast, circulation, modification, dissemination, or commercial exploitation such information in any manner (including electronic, print or other media now known or hereafter developed) is permitted.
DBS Group and its respective directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned and may also perform or seek to perform broking, investment banking and other banking or financial services to any persons or entities mentioned.
To the maximum extent permitted by law, DBS Group accepts no liability for any losses or damages (including direct, special, indirect, consequential, incidental or loss of profits) of any kind arising from or in connection with any reliance and/or use of the information (including any error, omission or misstatement, negligent or otherwise) or further communication, even if DBS Group has been advised of the possibility thereof.
The information is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. The information is distributed (a) in Singapore, by DBS Bank Ltd.; (b) in China, by DBS Bank (China) Ltd; (c) in Hong Kong, by DBS Bank (Hong Kong) Limited; (d) in Taiwan, by DBS Bank (Taiwan) Ltd; (e) in Indonesia, by PT DBS Indonesia; and (f) in India, by DBS Bank Ltd, Mumbai Branch.